BRANFORD, Conn., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, today reported financial results for the three and nine months ended September 30, 2016.
Net sales from continuing operations for the third quarter of 2016 increased 16% to $5.8 million, from $4.9 million for the third quarter of 2015. The Company incurred a net loss applicable to common stockholders for the third quarter of 2016 of $1.7 million, or $0.06 per share, compared with a net loss applicable to common stockholders for the third quarter of 2015 of $2.0 million, or $0.07 per share.
